Abstract
Original language | English |
---|---|
Pages (from-to) | A23-A27 |
Journal | Chest |
Volume | 162 |
Issue number | 4, Supplement |
Early online date | 31 Oct 2022 |
DOIs | |
Publication status | Published - Oct 2022 |
Event | CHEST Annual Meeting - Nashville, United States Duration: 16 Oct 2022 → 19 Oct 2022 https://www.chestnet.org/Learning-and-Events/Events/CHEST-Annual-Meeting |
Bibliographical note
FundingThis study was funded by AstraZeneca. The International Severe Asthma Registry is jointly funded by Optimum Patient Care Global and AstraZeneca.
Acknowledgments
Medical writing support was provided by Madeleine Wynn, MRes, of PharmaGenesis
London, London, UK, with funding from AstraZeneca.